Nilotinib: a second-generation tyrosine kinase inhibitor for the treatment of chronic myelogenous leukemia

scientific article

Nilotinib: a second-generation tyrosine kinase inhibitor for the treatment of chronic myelogenous leukemia is …
instance of (P31):
review articleQ7318358
scholarly articleQ13442814

External links are
P356DOI10.1016/J.CLINTHERA.2008.11.014
P698PubMed publication ID19108785

P2093author name stringCelalettin Ustun
Kavita Natarajan
David L Deremer
P433issue11
P921main subjectleukemiaQ29496
P304page(s)1956-1975
P577publication date2008-11-01
P1433published inClinical TherapeuticsQ15716601
P1476titleNilotinib: a second-generation tyrosine kinase inhibitor for the treatment of chronic myelogenous leukemia
P478volume30